Dodge & Cox – NVS history
- Issuer:
- Novartis AG
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 6,967,383
- Current value:
- $1.06B
- Peak shares:
- 13,165,538 (Q4 2023)
- Overall change:
- -47%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 6,967,383 | $1.06B | $152.75 | -2,047,258 | -23% |
| Q4 2025 | 9,014,641 | $1.24B | $137.87 | -1,570,504 | -15% |
| Q3 2025 | 10,585,145 | $1.36B | $128.24 | 0 | 0% |
| Q3 2025 | 10,585,145 | $1357.44B | $128240.00 | -62,484 | -1% |
| Q2 2025 | 10,647,629 | $1.29B | $121.01 | 0 | 0% |
| Q2 2025 | 10,647,629 | $1288.47B | $121010.00 | -1,170,473 | -10% |
| Q1 2025 | 11,818,102 | $1.32B | $111.48 | 0 | 0% |
| Q1 2025 | 11,818,102 | $1317.48B | $111480.00 | -396,563 | -3% |
| Q4 2024 | 12,214,665 | $1188.61B | $97310.00 | 0 | 0% |
| Q4 2024 | 12,214,665 | $1.19B | $97.31 | -7,211 | 0% |
| Q3 2024 | 12,221,876 | $1.41B | $115.02 | -14,650 | 0% |
| Q2 2024 | 12,236,526 | $1.30B | $106.46 | -117,459 | -1% |
| Q1 2024 | 12,353,985 | $1.20B | $96.73 | -811,553 | -6% |
| Q4 2023 | 13,165,538 | $1.33B | $100.97 | — | NEW |